UB Paderborn / Katalog / Suche / in CDI

Human pharmacokinetics of dihydroergotamine administered by nasal spray

Clinical pharmacology and therapeutics, 1996-09, Vol.60 (3), p.265-275

1996

Link zum Volltext

Verfügbarkeit prüfen

Confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e19505-e19505

2010

Link zum Volltext

Verfügbarkeit prüfen

PCN3 RELIABILITY OF CLINICIAN VS. CLINICIAN ADVERSE SYMPTOM REPORTING

Value in health, 2010, Vol.13 (3), p.A23-A23

2010

Link zum Volltext

Verfügbarkeit prüfen

Loss of Vision

Emergency medicine clinics of North America, 1995-08, Vol.13 (3), p.539-560

1995

Link zum Volltext

Verfügbarkeit prüfen

Efficient phosphate binding using a combination of gluconolactate and carbonate calcium salts

Journal of clinical pharmacy and therapeutics, 1994-08, Vol.19 (4), p.233-238

1994

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope

European journal of clinical pharmacology, 1989-01, Vol.37 (4), p.381-385

1989

Link zum Volltext

Verfügbarkeit prüfen

Influence of digestive secretions and food on intestinal absorption of nicardipine

European journal of clinical pharmacology, 1988-01, Vol.34 (2), p.165-171

1988

Link zum Volltext

Verfügbarkeit prüfen

Determination of pindolol in biological fluids by electron-capture GLC

Journal of pharmaceutical sciences, 1980-10, Vol.69 (10), p.1191-1193

1980

Link zum Volltext

Verfügbarkeit prüfen

Determination of 3-hydroxy-guanfacine in biological fluids by electron-capture gas—liquid chromatography

Journal of chromatography, 1982-12, Vol.233 (1), p.181-192

1982

Link zum Volltext

Verfügbarkeit prüfen

Determination of Guanfacine in Biological Fluids by Electron-Capture GLC

Journal of pharmaceutical sciences, 1979-02, Vol.68 (2), p.219-221

1979

Link zum Volltext

Verfügbarkeit prüfen

Estimation of the absolute oral bioavailability of pindolol by two analytical methods

European journal of clinical pharmacology, 1983, Vol.25 (3), p.357-359

1983

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure

European journal of clinical pharmacology, 1983-01, Vol.25 (4), p.463-466

1983

Link zum Volltext

Verfügbarkeit prüfen

Quantification of ketotifen and its metabolites in human plasma by gas chromatography mass spectrometry

Biological Mass Spectrometry, 1983-03, Vol.10 (3), p.136-142

1983

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of cloxazolam in man, after single and multiple oral doses (author's transl)

Therapie, 1980-07, Vol.35 (4), p.533

1980

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Hepatic Extraction Ratio of Pindolol in Hypertensive Patients with Normal and Impaired Renal Function

Journal of clinical pharmacology, 1977-08, Vol.17 (8-9), p.501-508

1977

Link zum Volltext

Verfügbarkeit prüfen

Guanfacine kinetics in patients with hypertension

Clinical pharmacology and therapeutics, 1979-03, Vol.25 (3), p.283-293

1979

Link zum Volltext

Verfügbarkeit prüfen

Pindolol availability in hypertensive patients with normal and impaired renal function

Clinical pharmacology and therapeutics, 1977-11, Vol.22 (5part1), p.505-510

1977

Link zum Volltext

Verfügbarkeit prüfen

Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response : application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922

Journal of pharmacokinetics and biopharmaceutics, 1991-06, Vol.19 (3), p.287-309

1991

Link zum Volltext

Verfügbarkeit prüfen

Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment

Journal of chromatography, 1987, Vol.417 (2), p.319-329

1987

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and metabolism of cyclosporin; drug interactions

Nephrologie, 1987, Vol.8 (3), p.135

1987

Link zum Volltext

Verfügbarkeit prüfen

Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment

Journal of chromatography. Biomedical applications, 1987, Vol.417, p.319-329

1987

Link zum Volltext

Verfügbarkeit prüfen

Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment

Journal of chromatography, 1987-07, Vol.417 (2), p.319

1987

Link zum Volltext

Verfügbarkeit prüfen

Using Confirmatory Factor Analysis to Evaluate Construct Validity of the Brief Pain Inventory (BPI)

Journal of pain and symptom management, 2011-03, Vol.41 (3), p.558-565

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)

Nephrologie, 1980, Vol.1 (2), p.73

1980

Link zum Volltext

Verfügbarkeit prüfen

The relation between anti-hypertensive action and plasmatic concentration of pindolol. Preliminary study

La Nouvelle presse medicale, 1977-03, Vol.6 (11), p.927

1977

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Human pharmacokinetics of dihydroergotamine administered by nasal spray

Confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI)

PCN3 RELIABILITY OF CLINICIAN VS. CLINICIAN ADVERSE SYMPTOM REPORTING

Loss of Vision

Efficient phosphate binding using a combination of gluconolactate and carbonate calcium salts

Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope

Influence of digestive secretions and food on intestinal absorption of nicardipine

Determination of pindolol in biological fluids by electron-capture GLC

Determination of 3-hydroxy-guanfacine in biological fluids by electron-capture gas—liquid chromatography

Determination of Guanfacine in Biological Fluids by Electron-Capture GLC

Estimation of the absolute oral bioavailability of pindolol by two analytical methods

Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure

Quantification of ketotifen and its metabolites in human plasma by gas chromatography mass spectrometry

Pharmacokinetics of cloxazolam in man, after single and multiple oral doses (author's transl)

Pharmacokinetics and Hepatic Extraction Ratio of Pindolol in Hypertensive Patients with Normal and Impaired Renal Function

Guanfacine kinetics in patients with hypertension

Pindolol availability in hypertensive patients with normal and impaired renal function

Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response : application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922

Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment

Pharmacokinetics and metabolism of cyclosporin; drug interactions

Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment

Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment

Using Confirmatory Factor Analysis to Evaluate Construct Validity of the Brief Pain Inventory (BPI)

Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)

The relation between anti-hypertensive action and plasmatic concentration of pindolol. Preliminary study

Suchergebnisse filtern